Latest Regulatory Approval News

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.

ADX Energy has lodged applications for two offshore gas exploration permits adjacent to its existing Sicily Channel licence, aiming to extend its footprint in a geologically promising biogenic gas play.

European Lithium and Critical Metals Corp have amended their merger terms to replace a fixed share exchange ratio with a floating ratio tied to Critical Metals' NASDAQ share price, potentially increasing shareholder value amid ongoing merger progress.

Ragusa Minerals has pinpointed 14 priority drill targets at its historic Black Rock Manganese Mine site in Arizona, following a detailed induced polarisation survey that reveals significant extensions of high-grade manganese mineralisation.

Patagonia Lithium’s Well 7 delivers strong porosity alignment between core and gamma surveys, with lithium levels near project averages. Preparations for Well 8 pump testing advance, while plans for Well 9 await regulatory approval.

Equus Energy's Pre-FEED study confirms a robust, phased development plan for its Equus Gas Project, targeting LNG, domestic gas, and condensate production with strong economic returns.

BCI Minerals edges closer to first salt shipment at its Mardie Project, with crystallisation underway and 85% construction complete. The company maintains full funding and advances its sulphate of potash opportunity alongside robust sustainability initiatives.

Taiko Critical Minerals has successfully closed a NZ$2.5 million Share Purchase Plan, issuing over 10 million shares at NZ$0.25 each to support the development of its Barrytown Critical Minerals Project.

Zenith Minerals and Forrestania Resources have amended their takeover implementation deed, updating key terms including offer conditions, board changes, and break fees as Forrestania pursues control.

Victory Metals (ASX: VTM) has delivered a robust Pre-Feasibility Study for its North Stanmore rare earth project, confirming a 47 Mt Probable Ore Reserve and strong economics underpinned by low capital intensity and a high-grade mineral resource.

Brazilian Rare Earths (ASX: BRE) has unveiled a scoping study for its Monte Alto and Camaçari project in Bahia, Brazil, showcasing ultra-high grades and robust economics with a post-tax NPV8 of US$6 billion and a rapid 1.1-year payback.